On May 28, 2022 FORUS reported that it was a proud sponsor and participant in the Défi Cyclo-Myélome (Press release, FORUS Therapeutics, MAY 28, 2022, View Source;utm_medium=rss&utm_campaign=forus-was-a-proud-sponsor-and-participant-in-the-defi-cyclo-myelome-on-may-28th-2022 [SID1234615259]). This is the 10th year of this important event which aims to increase awareness about multiple myeloma and raise funds for the Myeloma Canada Chair, held by Dr. Richard LeBlanc, at the Université de Montréal at Maisonneuve-Rosemont Hospital (HMR). Funds from this event will support research focused on improving the care of individuals living with multiple myeloma. Special recognition to Marie-Josèphe Champagne who rode on behalf of FORUS alongside other supporters, patients, caregivers and healthcare professionals.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!